During 2021, a moderate growth of 14% was observed, reaching $339 million of purchases in Central America from Mexico, where the main importer in the region was Guatemala with $83 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
More than 10 thousand results were observed during May 2022 in tenders under the heading "health and medicines", ranging from medical treatments to equipment and machinery used in the health sector.
An analysis by CentralAmericaData's Business Intelligence department shows interesting data on the processes that during May 2022 were published with contracts to provide pharmaceuticals, equipment and medical supplies to the several Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
A cut-off for the first quarter of the year shows a relevant figure in the health and medicine sector for the Central American region and the Dominican Republic.
An analysis of CentralAmericaData's Business Intelligence department shows interesting data on the processes that in the first quarter of 2022 were published with contracts to supply pharmaceuticals, equipment and medical supplies to the various Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
BID Invest granted Calox de Costa Rica S.A. a loan that will help the company invest in substantial improvements in its production capacity and seek international certifications to validate the quality of its products.
The project has two main objectives. The first is to acquire the existing plant to make improvements in infrastructure and energy efficiency in order to become certified and expand its production capacity in the medium term.
From January to March 2020, purchases of pharmaceutical products made by Central American countries from companies in Mexico totaled $73 million, 2% more than reported in the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
Agefinsa, Servicios Tecnicos Medicos, Macrotech Farmaceutica and J.I. Cohen are some of the companies that during the first quarter of the year won contracts to provide medicines and pharmaceutical products to public health institutions in the region.
The "Interactive Public Procurement Information System" of the Trade Intelligence Unit of CentralAmericaData provides interesting data on the companies that in the first quarter of 2020 were favored with contracts to provide pharmaceutical products and medical supplies to the various Ministries of Health and Social Security entities in the Central American countries.
As a result of the Coronavirus emergency, the CABEI granted each of the Central American countries financial resources for the purchase of medicines and medical supplies.
The international organization reported that it granted non-reimbursable financial cooperation in the amount of up to $8,000,000 distributed in $1,000,000 to each Central American country, including Belize, to attend to the health emergency.
From January to September 2019, pharmaceutical product imports in Central America totaled $2.614 million, 8% more than in the same period in 2018, with El Salvador, Panama and Costa Rica being the markets where purchases increased the most.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption "Click to interact with graphics"]
The Ministry of Health decided to withdraw all registered drugs containing oral ranitidine from the market, arguing that long-term exposure of people to this substance may increase the risk of cancer.
With the available data there is no evidence that the presence of this substance could have caused harm to patients who have consumed the drug, however, the potential risk arising from the cumulative effect, makes it necessary for health regulatory authorities to take different precautionary measures to avoid their presence in medicines, informed local authorities.
In the wholesale pharmaceutical distribution business, it is estimated that Cefa, Distribuidora Farmanova and Compañía Farmacéutica together represent about 65% of the market share.
Data from the report "Company's Corporate System", complied by the Business Intelligence Unit at CentralAmericaData, provides details on company information based on sector, main activity, imports, exports, contracts granted by the government and other data.
During the first half of the year, purchases of vaccines for human use in Central America totaled $57 million, and imports from France increased 83% over the same period in 2017.
Figures from the information system Vaccine Market for Human Use in Central America, from the Trade Intelligence Area of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
The market for medicines in Colombia up to 2017 totalled $3.419 billion, of which 83% corresponded to sales of prescribed medicines, and the remaining 17% to OTC medicines.
A report by the Foreign Trade Promotion Office of Costa Rica details the characteristics of the pharmaceutical products market in Colombia, and highlights the opportunities available for companies in Central America that sell raw materials and supplies for manufacturing medicines.
The Costa Rican Social Security Fund is putting out to tender a supply of various types of medicines.
Costa Rica Government Purchase 2018ME-000115-5101:
"Beclomethasone dipropionate 100 ug / dose in extra fine aerosol solution for oral inhalation, pressurized bottle with 200 doses, does not contain CFC, amount required 1,100,000."